Amneal Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 209.43M169.32M-201.30M-603.57M68.62M20.17M-254.83M-48.77M-73.91M
Depreciation and Depletion 29.31M41.96M64.42M63.28M60.42M60.70M68.10M66.20M62.60M
Share-based Compensation 167.60M21.68M20.75M28.41M31.85M26.82M27.77M
Deferred Taxes 0.12M0.74M-9.44M371.72M
Gains from Sales and Divestitures 0.48M
Gains from Investment Securities 4.92M5.81M6.18M100.14M-15.56M12.65M-14.50M15.22M
Asset Writedowns and Impairment 9.23M3.77M47.07M172.78M75.24M54.66M51.10M74.69M96.56M
Cash from Restructuring 11.29M
Non-cash Items 2.60M2.07M
Cash from Operations 115.06M234.19M250.23M1.71M379.00M241.82M65.10M345.58M295.10M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 3.06M5.00M5.86M6.48M8.68M9.20M8.60M11.55M29.10M
Depreciation & Amortization (CF) 33.02M45.94M137.40M207.24M235.39M233.41M240.18M229.40M236.19M
Change in Working Capital
Change in Receivables 122.48M-35.26M-89.08M132.73M-16.79M23.62M79.72M-126.29M162.64M
Change in Inventory 42.59M31.83M42.02M20.39M113.78M49.02M102.40M126.18M130.53M
Change in Account Payables 4.30M8.21M-14.11M5.23M1.65M-2.35M2.07M9.83M54.44M
Change in Accured Expenses 6.26M18.11M-53.55M-10.26M0.31M-43.93M109.57M-94.45M235.13M
Change in Taxes 34.95M
Other Working Capital Changes -2.04M25.30M-8.78M-38.87M-33.31M21.98M-9.88M-37.81M0.96M
Investing Activities
Capital Expenditures 122.76M94.77M83.09M47.18M56.45M47.73M46.41M43.22M51.92M
Sales of Property, Plant and Equipment 25.00M43.02M5.00M1.00M
Change in Intangibles 1.85M19.50M14.00M50.25M4.35M1.70M41.80M22.39M14.65M
Acquisitions 324.63M251.36M146.54M84.71M
Divestments 15.72M34.83M11.99M
Cash from Investing Activities -124.61M-98.55M-396.38M-19.58M-317.55M-194.18M-174.31M-69.19M-63.00M
Financing Activities
Other financing activities 6.51M5.03M54.95M4.10M1.66M162.41M
Cash from Financing Activities -19.50M-95.02M287.68M-45.83M131.81M-138.12M-106.62M-212.57M-211.79M
Dividend Payments
Dividends Paid - Common 200.62M375.26M183.00M
Additional items
Exchange Rate Effect 1.48M-0.24M-0.67M-2.25M1.04M0.10M-5.68M0.07M-1.00M
Change in Cash -27.56M40.38M140.86M-65.96M194.30M-90.38M-221.51M63.88M19.31M
Beginning Cash Balance 54.93M33.79M72.54M217.15M147.08M338.17M247.49M27.66M91.24M
Free Cash Flow -7.70M139.42M167.14M-45.48M322.56M194.09M18.69M302.36M243.18M
Net Cash Flow -29.04M40.62M141.53M-63.71M193.26M-90.48M-215.83M63.81M20.31M